Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel

被引:107
作者
McConathy, Walter J. [2 ]
Nair, Maya P. [1 ]
Paranjape, Sulabha [2 ]
Mooberry, Linda [1 ]
Lacko, Andras G. [1 ]
机构
[1] Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX 76107 USA
[2] Univ N Texas, Hlth Sci Ctr, Dept Internal Med, Ft Worth, TX 76107 USA
关键词
chemotherapy; drug delivery; nanoparticles; reconstituted (synthetic) high-density lipoprotein;
D O I
10.1097/CAD.0b013e3282f1da86
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Reconstituted (synthetic) high-density lipoprotein particles carrying paclitaxel (rHDL/PTX) were prepared with substantially higher PTX content than reported earlier. The rHDL/PTX complexes seemed to be primarily spherical nanoparticles when examined via electron microscopy, with a constant composition, molecular weight and exceptional stability even after ultracentrifugation and storage for up to 6 months. The rHDL/PTX nanoparticles; had superior cytotoxicity against several cancer cell lines (MCF7, DU145, OV1063 and OVCAR-3), the half maximal inhibitory concentration (IC50) having been found to be 5-20 times lower than that of the free drug. Studies with mice showed that the rHDL/PTX nanoparticles were substantially better tolerated than the corresponding dosages of either Taxol or Abraxane.
引用
收藏
页码:183 / 188
页数:6
相关论文
共 30 条
[1]  
Ackers G K, 1970, Adv Protein Chem, V24, P343, DOI 10.1016/S0065-3233(08)60245-4
[2]  
ARNOULD R, 1990, ANTICANCER RES, V10, P145
[3]  
Baillie G, 2002, J LIPID RES, V43, P69
[4]  
BREWER HB, 1986, METHOD ENZYMOL, V128, P223
[5]   A mutant high-density lipoprotein receptor inhibits proliferation of human breast cancer cells [J].
Cao, WM ;
Murao, K ;
Imachi, H ;
Yu, X ;
Abe, H ;
Yamauchi, A ;
Niimi, M ;
Miyauchi, A ;
Wong, NCW ;
Ishida, T .
CANCER RESEARCH, 2004, 64 (04) :1515-1521
[6]   LIPOPROTEINS AS POTENTIAL SITE-SPECIFIC DELIVERY SYSTEMS FOR DIAGNOSTIC AND THERAPEUTIC AGENTS [J].
COUNSELL, RE ;
POHLAND, RC .
JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (10) :1115-1120
[7]   LYSOSOMOTROPIC AGENTS .6. SELECTIVE DELIVERY OF CYTO-TOXIC COMPOUNDS TO CELLS BY THE LDL PATHWAY [J].
FIRESTONE, RA ;
PISANO, JM ;
FALCK, JR ;
MCPHAUL, MM ;
KRIEGER, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (08) :1037-1043
[8]   PLASMA LIPOPROTEINS IN FAMILIAL LECITHIN-CHOLESTEROL ACYLTRANSFERASE DEFICIENCY - STRUCTRUE OF LOW AND HIGH DENSITY LIPOPROTEINS AS REVEALED BY ELECTRON MICROSCOPY [J].
FORTE, T ;
NORUM, KR ;
GLOMSET, JA ;
NICHOLS, AV .
JOURNAL OF CLINICAL INVESTIGATION, 1971, 50 (05) :1141-&
[9]   LOW-DENSITY LIPOPROTEIN AS A POTENTIAL VEHICLE FOR CHEMOTHERAPEUTIC-AGENTS AND RADIONUCLEOTIDES IN THE MANAGEMENT OF GYNECOLOGIC NEOPLASMS [J].
GAL, D ;
OHASHI, M ;
MACDONALD, PC ;
BUCHSBAUM, HJ ;
SIMPSON, ER .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1981, 139 (08) :877-885
[10]   Uptake of high density lipoprotein (HDL) cholesteryl esters by human acute leukemia cells [J].
Gonçalves, RP ;
Rodrigues, DG ;
Maranhao, RC .
LEUKEMIA RESEARCH, 2005, 29 (08) :955-959